Latest Period
Q1 2026
CUSIP: 022307102
Latest Period
Q1 2026
Institutions Reporting
193
Shares (Excl. Options)
99,368,255
Price
$22.03
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 193 institutions filings for Q1 2026.
Security key
022307102
Latest holder period
Q1 2026
13F holders
193
13D/G owners
5
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 022307102:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Foresite Capital Fund VI LP | 13% | -10% | $422,163,758 | -$13,341,970 | 15,693,820 | -3.1% | James B. Tananbaum | 01 Apr 2026 |
| AyurMaya Capital Management Company, LP | 16% | -29% | $65,554,931 | +$19,457,899 | 15,139,707 | +42% | AyurMaya Capital Management Company, LP | 21 May 2025 |
| Deep Track Capital, LP | 6% | $162,185,631 | 7,362,035 | Deep Track Capital, LP | 30 Mar 2026 | |||
| Samsara BioCapital, L.P. | 5.4% | +2% | $61,929,972 | +$11,811,946 | 6,345,219 | +24% | Srinivas Akkaraju | 09 Jan 2026 |
| venBio Global Strategic Fund IV, L.P. | 4.8% | $21,297,292 | 4,619,803 | venBio Global Strategic Fund IV, L.P. | 30 Jun 2025 |
As of 31 Mar 2026, 193 institutional investors reported holding 99,368,255 shares of ALUMIS INC. - Common Stock, $0.0001 par value per share (ALMS). This represents 81% of the company’s total 123,110,953 outstanding shares.
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.8% | 7,170,868 | +57% | 0% | $157,974,221 |
| Deep Track Capital, LP | 5.5% | 6,772,595 | 3.1% | $149,200,268 | |
| SAMSARA BIOCAPITAL, LLC | 5.2% | 6,345,219 | +10% | 14% | $139,785,175 |
| Foresite Capital Management V, LLC | 4.8% | 5,896,995 | +2% | 48% | $129,910,800 |
| venBio Partners LLC | 3.7% | 4,528,408 | -2% | 36% | $99,760,828 |
| Foresite Capital Management VI LLC | 3.5% | 4,247,670 | 0% | 20% | $93,576,170 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 4,032,266 | 0% | 0% | $88,830,820 |
| Cormorant Asset Management, LP | 3.2% | 3,949,241 | +8.6% | 4.4% | $87,001,779 |
| Nextech Invest, Ltd. | 2.9% | 3,540,998 | +21% | 5.5% | $78,008,186 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.7% | 3,286,753 | +6418% | 0.01% | $72,408,000 |
| Saturn V Capital Management LP | 2.6% | 3,202,075 | +2.1% | 13% | $70,541,712 |
| UBS Group AG | 2.5% | 3,054,865 | +2580% | 0.01% | $67,298,676 |
| Octagon Capital Advisors LP | 2.3% | 2,830,700 | +12% | 6.9% | $62,360,321 |
| MPM BIOIMPACT LLC | 1.9% | 2,386,529 | -0.64% | 4.1% | $52,575,234 |
| JANUS HENDERSON GROUP PLC | 1.7% | 2,124,408 | 0.02% | $46,790,086 | |
| BAKER BROS. ADVISORS LP | 1.6% | 2,012,500 | +29% | 0.25% | $44,335,375 |
| SR One Capital Management, LP | 1.6% | 1,959,896 | 0% | 4.7% | $43,176,509 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,918,415 | +29% | 0% | $42,273,719 |
| STATE STREET CORP | 1.5% | 1,801,812 | +43% | 0% | $39,693,918 |
| Invesco Ltd. | 1.2% | 1,511,537 | +258% | 0.01% | $33,299,161 |
| Ikarian Capital, LLC | 0.99% | 1,213,548 | 3.8% | $26,734,462 | |
| MARSHALL WACE, LLP | 0.95% | 1,172,749 | +214% | 0.03% | $25,835,661 |
| Weiss Asset Management LP | 0.89% | 1,097,417 | 0.45% | $24,176,097 | |
| PRINCIPAL FINANCIAL GROUP INC | 0.86% | 1,058,051 | 0.01% | $23,308,865 | |
| FMR LLC | 0.79% | 973,782 | +3960% | 0% | $21,452,419 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 99,368,255 | $2,187,300,329 | +$771,560,759 | $22.03 | 193 |
| 2025 Q4 | 78,901,192 | $770,079,479 | +$72,305,373 | $9.76 | 132 |
| 2025 Q3 | 77,994,182 | $311,197,950 | -$66,383 | $3.99 | 129 |
| 2025 Q2 | 78,328,492 | $234,986,451 | +$114,158,793 | $3.00 | 112 |
| 2025 Q1 | 40,203,252 | $246,848,226 | -$2,907,402 | $6.14 | 72 |
| 2024 Q4 | 40,261,542 | $316,456,858 | +$6,196,390 | $7.86 | 64 |
| 2024 Q3 | 35,212,710 | $376,073,647 | +$60,319,979 | $10.68 | 52 |
| 2024 Q2 | 28,575,030 | $380,047,605 | +$380,047,605 | $13.30 | 29 |